Moreover, the expression of TIGAR in human breast cancer was found inversely correlated to the levels of p53.13 Taken together, these data suggest that TIGAR can function in a tumour suppressor pathway as part of a p53 response, but may also contribute to cancer development when TIGAR expression is deregulated and uncoupled from p53. Here, TP53 is linked to breast cancer.